249 related articles for article (PubMed ID: 6591152)
1. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.
Arnt J; Hyttel J; Overø KF
Pol J Pharmacol Pharm; 1984; 36(2-3):221-30. PubMed ID: 6591152
[TBL] [Abstract][Full Text] [Related]
2. Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram.
Arnt J; Overø KF; Hyttel J; Olsen R
Psychopharmacology (Berl); 1984; 84(4):457-65. PubMed ID: 6441945
[TBL] [Abstract][Full Text] [Related]
3. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.
Bonaventure P; Kelly L; Aluisio L; Shelton J; Lord B; Galici R; Miller K; Atack J; Lovenberg TW; Dugovic C
J Pharmacol Exp Ther; 2007 May; 321(2):690-8. PubMed ID: 17314195
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and pharmacological evaluation of the novel antidepressant and serotonin uptake inhibitor 2-(3,4-Dichlorobenzyl)-2-dimethylamino-1-propanol hydrochloride.
Gouret CJ; Porsolt R; Wettstein JG; Puech A; Soulard C; Pascaud X; Junien JL
Arzneimittelforschung; 1990 Jun; 40(6):633-40. PubMed ID: 2168703
[TBL] [Abstract][Full Text] [Related]
5. Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain.
Klimek V; Zak-Knapik J; Mackowiak M
J Psychiatry Neurosci; 1994 Jan; 19(1):63-7. PubMed ID: 8148368
[TBL] [Abstract][Full Text] [Related]
6. Serotonergic modulation of footshock induced aggression in paired rats.
Datla KP; Mitra SK; Bhattacharya SK
Indian J Exp Biol; 1991 Jul; 29(7):631-5. PubMed ID: 1839019
[TBL] [Abstract][Full Text] [Related]
7. The effect of repeated administration of imipramine, citalopram and mianserin on responsiveness of central serotonergic, alpha 2-adrenergic and cholinergic system in mice.
Maj J; Rogóz Z; Skuza G; Sowińska H
Pol J Pharmacol Pharm; 1989; 41(4):313-9. PubMed ID: 2561380
[TBL] [Abstract][Full Text] [Related]
8. Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus.
Galzin AM; Moret C; Verzier B; Langer SZ
J Pharmacol Exp Ther; 1985 Oct; 235(1):200-11. PubMed ID: 2864432
[TBL] [Abstract][Full Text] [Related]
9. Effects of subchronic antidepressant drug treatment on central serotonergic mechanisms in the male rat.
Fuxe K; Ogren SO; Agnati LF; Andersson K; Eneroth P
Adv Biochem Psychopharmacol; 1982; 31():91-107. PubMed ID: 7080902
[TBL] [Abstract][Full Text] [Related]
10. Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.
Langer SZ; Moret C
J Pharmacol Exp Ther; 1982 Jul; 222(1):220-6. PubMed ID: 6953233
[TBL] [Abstract][Full Text] [Related]
11. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
Millan MJ; Newman-Tancredi A; Rivet JM; Brocco M; Lacroix P; Audinot V; Cistarelli L; Gobert A
J Pharmacol Exp Ther; 1997 Jul; 282(1):132-47. PubMed ID: 9223549
[TBL] [Abstract][Full Text] [Related]
12. Time-dependent effects of antidepressant drugs on the low dose of apomorphine-induced locomotor hypoactivity in rats.
Dziedzicka-Wasylewska M; Rogóz Z
Pol J Pharmacol; 1997; 49(5):337-43. PubMed ID: 9566033
[TBL] [Abstract][Full Text] [Related]
13. The citalopram/5-HTP-induced head shake syndrome is correlated to 5-HT2 receptor affinity and also influenced by other transmitters.
Arnt J; Hyttel J; Larsen JJ
Acta Pharmacol Toxicol (Copenh); 1984 Nov; 55(5):363-72. PubMed ID: 6152104
[TBL] [Abstract][Full Text] [Related]
14. Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram.
Hyttel J; Overø KF; Arnt J
Psychopharmacology (Berl); 1984; 83(1):20-7. PubMed ID: 6429698
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of dopamine D-2, 5-HT2 receptors and beta-adrenoceptors in rat brain after prolonged treatment with a new potential antidepressant, Lu 19-005.
Nowak G; Arnt J; Hyttel J; Svendsen O
J Neural Transm; 1985; 64(3-4):227-38. PubMed ID: 2418155
[TBL] [Abstract][Full Text] [Related]
16. [Changes in 5-HT2 receptor density induced by repeated treatment with 5-HT uptake inhibitor or 5-HT agonist].
Kubota M; Ueno K; Yamano M; Kitagawa H
Yakubutsu Seishin Kodo; 1989 Sep; 9(3):289-92. PubMed ID: 2603573
[TBL] [Abstract][Full Text] [Related]
17. Receptor alterations associated with serotonergic agents: an autoradiographic analysis.
Wamsley JK; Byerley WF; McCabe RT; McConnell EJ; Dawson TM; Grosser BI
J Clin Psychiatry; 1987 Mar; 48 Suppl():19-25. PubMed ID: 3029045
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic citalopram treatment on 5-HT1A and 5-HT2A receptors in group- and isolation-housed mice.
Günther L; Liebscher S; Jähkel M; Oehler J
Eur J Pharmacol; 2008 Sep; 593(1-3):49-61. PubMed ID: 18657534
[TBL] [Abstract][Full Text] [Related]
19. Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.
Cohen ML; Fuller RW; Kurz KD; Parli CJ; Mason NR; Meyers DB; Smallwood JK; Toomey RE
J Pharmacol Exp Ther; 1988 Jan; 244(1):106-12. PubMed ID: 3335993
[TBL] [Abstract][Full Text] [Related]
20. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.
Pawłowski L; Siwanowicz J; Bigajska K; Przegaliński E
Pol J Pharmacol Pharm; 1985; 37(2):179-96. PubMed ID: 4048012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
